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Abstract
Background: The main aim of this study is to review the agenda for research priorities of mental 
health in Brazil. Methodology: The first step was to gather 28 experts (22 researchers, five policy 
makers, and the coordinator) representing all mental health fields from different geographical 
areas of the country. Participants were asked to list what they considered to be the most relevant 
mental health research questions for the country to address in the next 10 years. Seventeen 
participants answered this question; after redundancies were excluded, a total of 110 responses 
were collected. As the second step, participants were asked to rank which questions were the 
35 most significant. The final step was to score 15 items for each of the 35 selected questions 
to determine whether it would be a) answerable, b) effective, c) deliverable, d) equitable, and 
e) effective at reducing the burden of mental health. The ten highest ranked questions were 
then selected. Results: There were four questions addressing primary care with respect to a) the 
effectiveness of interventions, b) “matrix support”, c) comparisons of different models of stepped 
care, and d) interventions to enhance identification and treatment of common mental disorders 
at the Family Health Program. The other questions were related to the evaluation of mental 
health services for adults and children/adolescents to clarify barriers to treatment in primary 
care, drug addiction, and severe mental disorders; to investigate the cost-benefit relationship 
of anti-psychotics; to design interventions to decrease alcohol consumption; and to apply new 
technologies (telemedicine) for education and supervision of non-specialists. Conclusion: This 
priority-setting research exercise highlighted a need for implementing investments at the primary-
care level, particularly in the family health program; the urgent need to evaluate services; and 
policies to improve equity by increasing accessibility to services and testing interventions to 
reduce barriers for seeking mental health treatment. 
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Agenda de prioridades de pesquisa para saúde mental no Brasil
Resumo
Introdução: O principal objetivo desse estudo foi revisar a agenda de prioridades em pesquisa em 
saúde mental no Brasil. Método: Foram selecionados 28 especialistas (22 pesquisadores, cinco 
legisladores e o coordenador) de diferentes regiões. Responderam ao que consideravam mais 
relevante em pesquisa para a saúde mental para os próximos 10 anos. Dezessete responderam e 
configuraram 110 questões, que foram reavaliadas por eles, com atribuição de escore, a partir de 
15 itens distribuídos segundo grau de responsividade, eficácia, aplicabilidade, equidade e impacto 
na redução da carga da doença mental. 35 questões, e dentre elas as 10 mais bem pontuadas, 
foram destacadas. Resultados: Prevaleceram indicações para estudos de efetividade das inter-
venções, matriciamento, comparação entre modelos de intervenção e detecção e tratamento 
de transtornos mais prevalentes na Estratégia da Saúde da Família. Avaliação de serviços quanto 
às barreiras ao tratamento; custo-efetividade dos antipsicóticos, intervenções contra efeitos do 
álcool e outras drogas, e aplicação de tecnologias (telemedicina) para educação e supervisão dos 
generalistas foram outros. Conclusão: Apontou-se para necessidade de investimentos na saúde 
mental na atenção primária à saúde; avaliação do sistema de serviços de cuidados de saúde mental, 
e pesquisas para romper barreiras ao acesso e à equidade no tratamento dos transtornos mentais. 
DESCRITORES:
Serviços de saúde 
mental;
Prioridades em saúde;
Agenda de prioridades 
em saúde;
Dotação de recursos 
para cuidados de saúde. 
Introduction
Mental disorders account for 14% of the global burden 
of disease.1 By 2020, it is predicted that depression will 
be the second-leading cause of disease burden.2 In ad-
dition, substance abuse disorders contribute to more 
than 4% of the total burden.3 In Brazil, in 2003, neu-
ropsychiatric disorders accounted for 18% of Disability 
Adjusted Lost Years (DALYs) and 35% of the Years Lost 
due to Disability (YLDs).4 The high burden of neuropsy-
chiatric disorders in low- and middle-income countries 
(LAMIC) is contrasted with low investments in mental 
health:5,6 most of the LAMIC spend less than 1% of the 
total health budget on mental health.5,7-10 The high 
morbidity and low investments are important factors in 
explaining why a minority of individuals with mental and 
substance disorders (MSDs) ever receive treatment.11 In 
addition, MSDs comprise the leading cause of disability 
in young people in every region of the world.12 
 Increasingly, there is a need to set priorities in health 
research by allocating investments in a fair and legitimate 
way on the basis of sound and transparent methodologies. 
The explicit and rational setting of priorities for invest-
ment in research is now accepted as an integral part of 
any research management process.16 Research can play a 
critical role in the response to global health challenges, 
but it is crucial to adopt some basic assumptions when 
making decisions to allocate investments in health re-
search. As part of the National Priority Health Research 
Agenda established by the Brazilian Ministry of Health,17 
the main aim of this exercise is to review the agenda for 
mental health research priorities by adopting the Child 
and Nutrition Research Iniciative (CNRI) method.18 This 
is a transparent and systematic process, where the out-
come of the research is based on the following principles: 
a) reduction of the burden, b) promotion of equity, and 
c) promotion of health and wellbeing. 
Methods
The Brazilian Ministry of Health convened a meeting on 
September 21, 2010, aimed at reviewing the National Agenda 
for Health Research Priorities. One of the authors (JJM) was 
appointed to coordinate the mental health component of this 
exercise. JJM was responsible for selecting the experts in spe-
cific mental health areas and ensuring gender and geographical 
representativeness. The coordinator adopted the following cri-
teria for the selection of experts: equitable distribution based 
on gender, geography, and areas of knowledge; the impact 
of their scientific research; and their availability for replying to 
the questionnaires. The head of the Mental Health Division, 
Prof. Pedro Gabriel Delgado, was responsible for selecting 
mental health administrators and experts in policy making. 
The Child and Nutrition Research Initiative (CNRI), a priority-
setting methodology developed by Rudan et al.19 that had been 
previously used to establish mental health priorities on a global 
level, was adopted for this exercise.18 The CNRI methodology 
defines the context in which prioritization takes place (in this 
case Brazil). It then defines a set of criteria that will be used 
to set priorities among many competing research investment 
options. Those research investment options are then listed in 
a systematic and structured way. The rationale, conceptual 
framework, and application guidelines for CNRI methodology 
have all been described in detail elsewhere.20 
Technical working group
Table 1 presents the steps for implementation of the method-
ology at a glance. In the first step, as stated above, a group 
of experts from different mental health domains were recruited. 
Experts included infant and child psychiatrists, geriatric psy-
chiatrists, and specialists in drug addiction and primary care. 
The time scale for the exercise was ten years. The next step 
was to create a list of research questions, which were divided 
into five domains: a) epidemiological research or research 
to inform priority setting, b) research to improve the efficiency 
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of health systems already in place, c) research to improve the 
efficiency of health systems already in place, focusing on health 
policy and systems, d) research to improve the affordability 
and deliverability of existing interventions, and e) research to 
develop new health interventions. 
The third step was to score the listed questions by five 
criteria: a) the likelihood of answerability in an ethical 
way, b) the likelihood of efficacy and effectiveness, c) 
the likelihood of deliverability and affordability, d) the 
maximum potential for disease burden reduction, and e) 
the likely impact of equity in the population (see Box 1 
for a list of the questions). 
Table 1 Recruitment and Technical Working Group 
Step 1 Recruited a group of experts from different mental health 
domains
the time frame for the exercise was ten years
28 participants (22 researchers, 5 policy makers, and 
the coordinator). Participants were asked to list relevant 
mental health research questions on their own, to consult 
the Brazilian Agenda for Health Research Priorities,17 or 
to consult the mental health research priorities list 
reported by the Lancet expert group for middle and  
low income contries10
Step 2 Create a list of research questions in five domains:
1. epidemiological research or research to inform priority 
setting
2. research to improve the efficiency of the health system 
already in place
3. research to improve the efficiency of the health system 
already in place focusing on health policy and systems
4. research to improve the affordability and deliverability of 
existing interventions
5. research to develop new health interventions
Step 3 Score the listed questions by five criteria:
1. likelihood of answerability in an ethical way
2. likelihood of efficacy and effectiveness
3. likelihood of deliverability and affordability
4. maximum potential for the reduction of disease burden 
5. likely impact of equity in population
15 participants replied to the questionnaire by e-mail.  
The minimum number of votes among questions selected 
was five. 35 questions were selected (Appendix)
Box 1 Questions used by technical experts to assign 
intermediate scores to competing research questions 
Criterion 1: likelihood that research would lead to new knowledge 
(enabling development or planning of an intervention) in an ethical way 
1. Would you say the research question is well framed and end-points 
are well defined? 
2. Based on the level of existing research capacity in the proposed 
research area and the size of the gap between the current level of 
knowledge and the proposed end-points, would you say that a study 
could be designed to answer the research question and to reach the 
proposed end-points of the research? 
3. Do you think that a study needed to answer the proposed research 
question would obtain ethical approval without major concerns? 
Box 1 Questions used by technical experts to assign 
intermediate scores to competing research questions (cont.)
Criterion 2: assessment of the likelihood that the intervention resulting 
from the proposed research would be effective 
1. Based on the best existing evidence and knowledge, would an 
intervention that was developed or improved through the proposed 
research be efficacious? 
2. Based on the best existing evidence and knowledge, would an 
intervention that was developed or improved through proposed 
research be effective? 
3. If the answer to either of the previous two questions is positive, 
would you say that the evidence on which these opinions are based 
is of high quality? 
Criterion 3: assessment of deliverability, affordability and sustainability 
of the intervention resulting from proposed research 
1. Taking into account the level of difficulty in delivering the 
intervention from the perspective of the intervention itself (e.g., 
design, standardization, safety), the infrastructure required (e.g., 
human resources, health facilities, communication and transport 
infrastructure) and users of the intervention (e.g., need for change 
of attitudes or beliefs, supervision, and existing demands), would 
you say that the end-points of the research would be deliverable 
within the context of interest? 
2. Taking into account the resources available to implement the 
intervention, would you say that the end-points of the research 
would be affordable within the context of interest? 
3. Taking into the account government capacity and partnership 
requirements (e.g., the adequacy of government regulation 
monitoring and enforcement; governmental inter-sectoral 
coordination; partnerships with civil society and external donor 
agencies; favorable political climate to achieve high coverage), 
would you say that the end-points of the research would be 
sustainable within the context of interest? 
Criterion 4: assessment of maximum potential of disease burden 
reduction 
This dimension is considered “independent” of the others. To score 
competing options fairly, the maximum potential to reduce disease 
burden should be assessed as the potential impact fraction under 
an ideal scenario. Reviewers should assume, for example, that the 
exposure to a targeted disease risk is decreased to 0% or that the 
coverage of a proposed intervention is increased to 100%, regardless of 
how realistic that scenario currently is– that aspect will be captured by 
other dimensions of the priority-setting process, such as deliverability, 
affordability and sustainability. 
The following questions should then be answered: 
1. Based on the results of completed intervention trials (i.e., existing 
interventions) or, for the new interventions, the proportion 
of preventable burden under an ideal scenario (i.e., potential 
interventions), would you say that the successful completion of 
research end-points would have the capacity to remove 5% of the 
total disease burden or more? 
2. to remove 10% of the disease burden or more? 
3. to remove 15% of the disease burden or more? 
Criterion 5: assessment of the impact of the proposed health research 
on equity 
1. Would you say that the present distribution of the disease burden 
affects mainly the underprivileged in the population? 
2. Would you say that either mainly the underprivileged, or all 
segments of society equally would be the most likely to benefit from 
the results of the proposed research after its implementation? 
3. Would you say that the proposed research has the overall potential 
to improve equity in the distribution of disease burden in the long 
term (e.g., 10 years)? 
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Participants 
The technical working group consisted of 28 participants (22 re-
searchers, five policy makers, and the coordinator). Participants 
were asked to list relevant mental health research questions on 
their own, to consult the National Agenda for Health Research 
Priorities,17 or to consult the LAMIC mental health research priori-
ties list reported by the Lancet expert group.10 Seventeen partici-
pants provided 110 questions distributed in the following areas: 
a) Epidemiological research or research to inform prior-
ity setting (27 questions); 
b) Research to improve efficiency of health systems 
already in place (35 questions); 
c) Research to improve efficiency of health systems al-
ready in place focusing on health policy and systems 
(18 questions); 
d) Research to improve affordability and deliverability 
of existing interventions (11 questions);
e) Research to develop new mental health interventions.
(19 questions).
In the second stage of the process, the questions were 
emailed to all participants. Participants were then asked 
to rank which were the most relevant 35 questions, taking 
into consideration the following points: a) the likelihood of 
answerability in an ethical way, b) the likelihood of efficacy 
and effectiveness, c) the likelihood of deliverability and 
affordability, d) the maximum potential for disease burden 
reduction, and e) the likely impact of equity in the population 
(Box 1). Fifteen (56%) participants replied to the questionnaires. 
The shortened 35-question list is displayed in Appendix 1. 
All included questions received at least five votes.
Results
The final results (top ten and bottom ten) of the scoring 
process, broken down by disorder, are shown in Table 2. 
The 10 most highly weighted questions, which we deem 
the top 10 priorities, are listed in Table 1. Four of the top 
10 priorities (the first, second, ninth and tenth) relate to 
Table 2 The list of the top ten priorities 
Top Ten – highest priority 
Questions Ans Eff Deliv Imp Equit WS 
Q03 - Studies on the cost-effectiveness of combined interventions 
(psychopharmacological and psychosocial) to prevalent and/
or disabling mental disorders conducted by interdisciplinary and 
multidisciplinary teams in the primary care setting, particularly for 
mental disorders that affect children and adolescents.
64.71 35.29 70.59 52.94 76.47 69.02 
Q01 - Interventions to identify and treat common mental disorders 
in primary care, especially in the Family Health Strategy, with active 
involvement of non-medical professionals in Family Health Teams.
47.06 41.18 82.35 58.82 64.71 69.02 
Q02 - Pharmacoeconomic studies to determine the cost-effectiveness 
of psychotropic drugs used in the public health system.
29.41 17.65 88.24 58.82 58.82 65.10 
Q17 - Research to establish what are the most effective policies 
to control the consumption of alcohol and drugs at the population 
level, such as taxation, availability of alcoholic beverages, control of 
marketing, and specific policies to prevent drinking and driving.
64.71 35.29 64.71 76.47 70.19 65.10 
Q12 - Telemedicine for psychiatric consultation for non-psychiatrist 
physicians.
47.06 29.41 58.82 70.59 70.59 59.22 
Q13 - Study of the barriers to access to treatment for individuals with 
severe and persistent mental disorders and drug addiction.
41.18 29.41 70.59 58.82 47.06 59.22 
Q04 - Epidemiological and social cost studies with a focus on the 
demands for mental health that reach primary health care units,  
and with an emphasis on coverage gaps and identification of barriers 
to access to treatment.
52.94 41.18 82.35 58.82 64.71 58.82 
Q 18 - Research with a nationally representative sample on the 
effectiveness and efficiency of the national mental health care policy 
(focused on general and childhood Psychosocial Care Centers - CAPS 
and CAPSi) for those affected by prevalent and/or disabling mental 
disorders, especially for mental disorders that affect children and 
adolescents.
47.06 23.53 58.82 64.71 58.82 58.82 
Q05 - Studies on the effectiveness of primary care and integrated 
care (“matrix support”) in the resolution of cases of mental 
disorders.
41.18 35.29 70.59 64.71 76.47 57.65 
Q31 - Cost-effectiveness study of different models 47.06 35.29 58.82 52.94 47.06 55.69 
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the identification and treatment of common mental dis-
orders in primary care. The third priority is to determine 
the cost-effectiveness of psychotropic drugs used in public 
health. The fourth priority was to implement interventions 
to control the consumption of alcohol and drugs at the 
population level, and the fifth priority was to investigate 
the use of telemedicine for psychiatric consultation for pa-
tients of non-psychiatrist physicians. The sixth and seventh 
priorities involve the identification of barriers to the access 
to treatment. The eighth priority involves the study of the 
effectiveness and coverage of the Community Psychosocial 
Centers for adults (CAPS-A) and children and adolescents 
(CAPS-i), in treating those affected by prevalent and/or 
disabling mental disorders.
Discussion
The results of this priority-setting process indicate that to 
significantly reduce the burden mental disorders in Brazil, 
research should concentrate on devising interventions at the 
primary-care level, evaluating existing mental health service 
policies, examining the cost-effectiveness of antipsychotics 
in Brazil, developing interventions to decrease alcohol con-
sumption, identifying barriers to treatment, and using new 
technologies to train and supervise non-specialists. 
The main actions recommended at the primary-care level, 
particularly in the Family Health Program (PSF), are as fol-
lows: a) to assess the effectiveness of interventions, b) to 
study matrix support, c) to study different models of stepped 
care, and d) to develop interventions that identify and treat 
common mental disorders within the Family Health Program. 
The recommendations particularly emphasize development 
at the primary-care level rather than using expensive tech-
nologies and specialized human resources. 
Child and adolescent mental health problems are common, 
affecting between 10% and 20% of children worldwide. They 
are even more relevant in LAMIC, where youth constitutes up 
to 50% of the total population.12 Future research is needed to 
address innovative ways to promote collaboration among gen-
eral health programs and sectors such as education and justice 
as well as to evaluate strategies to prevent mental disorders 
and to implement cost-effective interventions.21 
One of the questions is related to the most effective 
policies to control the consumption of alcohol and drugs at 
the population level, such as taxation, availability of alco-
holic beverages, control of marketing, and specific policies 
to prevent drinking and driving. It is widely recognized that 
the early use of alcohol is related to negative performance 
in school, unsafe sex, development of abnormal behavior, 
and a higher risk of developing alcohol dependence in adult-
hood. According to national probabilistic research conducted 
in Brazil,15 almost half of the 36% of 14 to 17-year-old 
boys who drink at least once a year have consumed three 
or more drinks at once. The priorities focus on alcohol 
largely because of the high burden of mortality and 
morbidity in Brazil due to traffic-related injuries.22 Recent 
policies in Brazil have focused on alcohol prevention, but 
little has been done to assess whether these policy changes 
have been effective. 
The questionnaire is somewhat long, requiring ap-
proximately one hour to reply, and only 56% of the selected 
experts completed the questionnaires in the last part of the 
survey. The coordinator arbitrarily selected the experts, and 
different participants might have achieved different results. 
Even taking these limitations into account, this exercise can 
be regarded as a solid method for setting national research 
priorities in Brazil. Emphasis was placed on prioritizing com-
munity investments, mostly at the level of family health 
programs, and two main focuses were selected as the major 
targets of future investigations, children and adolescents, 
and alcohol addiction. Moreover, this agenda highlights the 
need for cost-benefit analyses of psychosocial interventions 
and psychotropic drugs, the evaluation of current mental 
health services, the determination of local barriers to 
treatment, and the evaluation of telemedicine to supervise 
non-specialists. 
Conclusion
This exercise demonstrated the feasibility of applying a 
systematic methodology to establish an agenda for mental 
health priorities in Brazil. This strategy should be adopted 
by other LAMIC for the rational allocation of scarce resources 
and fostering of equity in society. This agenda could be used 
to foster investments in the areas determined by experts to 
be the most relevant research priorities, with the overall 
goal of decreasing disease burden and improving the quality 
of life of patients and their families in Brazil. 
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